The evolving management of aHUS: what clinicians need to know

Sponsored by Alexion Pharmaceuticals Australasia Pty Ltd

“Atypical haemolytic uraemic syndrome (aHUS) is one disease where you really don’t want to wait until you see clinical signs until you act. By that stage there’s already end-organ damage and with that comes a whole raft of complexities,” notes Danny Hsu, Consultant Haematologist, Liverpool Hospital. The limbic spoke with Dr Hsu about how the ...

Already a member?

Login to keep reading.

© 2021 the limbic